GLP-1s and the Lungs: Semaglutide Linked to 40% Fewer Asthma Attacks
New real-world data from the ERS Congress 2026 (Barcelona) Semaglutide was associated with up to a 40% reduction in asthma attacks, according…
A $3 Billion Company Is Being Built Around One of Pharmacy’s Biggest Opportunities: Medication Access
A prescription only creates value if the patient can actually start the therapy. Investors are now putting billions behind the infrastructure…
One of Cardiology’s Most Promising Drug Targets Just Failed Its First Big Test — And the Lp(a) Race Is Now Wide Open
Earlier this year, the ACC and AHA made a major change to cholesterol screening: the 2026 guideline says every adult should have their…
A Firm Managing $75 Billion Just Bought a Company Reaching 85% of U.S Pharmacies. Follow the Money.
The future of pharmacy may depend less on proving pharmacists can create value and more on building the infrastructure that can measure,…
The First Continuous Ketone Sensor Just Got Cleared – Abbott Closes Diabetes Monitoring’s Oldest Blind Spot
For four decades, ketone testing meant a urine strip or a fingerstick giving a single snapshot, no trend, and only if the patient remembered…